Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification
Frédéric Le Gal(Sorbonne Université), Emmanuel Gordien(Inserm), Ségolène Brichler(Inserm), Zahia Ben Abdesselam(Université Paris Cité), Dominique Roulot(Hôpital Avicenne), Samira Dziri(Université Paris Cité), Athénaïs Gerber(Université Paris Cité), Chakib Alloui(Université Paris Cité)
Cited by 51
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206
Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein
|Journal of Virology|2001|185